You have 9 free searches left this month | for more free features.

City

Houston (1)

Seongnam-si (1)

Seoul (1)

Condition

Advanced Solid Tumor (1)

Pancreas Cancer (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Phase

phase 1 (2)

Sponsor

ImmunoMet Therapeutics, Inc. (1)

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

im156 (2)

gemcitabine (1)

nab paclitaxel (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

im156

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pancreas Cancer Trial in Houston (Gemcitabine, Nab paclitaxel, IM156)

Not yet recruiting

Pancreas Cancer

Gemcitabine
+2 more

Houston, Texas

MD Anderson Cancer Center

Aug 15, 2022

Advanced Solid Tumor Trial in Seongnam-si, Seoul (IM156)

Completed

Advanced Solid Tumor

IM156

Seongnam-si, Gyeonggi-do, Korea, Republic of
+2 more

Oct 15, 2020